ID: ALA5278759

Max Phase: Preclinical

Molecular Formula: C13H8O8

Molecular Weight: 292.20

Associated Items:

Representations

Canonical SMILES:  O=C1CC(C(=O)O)c2c1oc(=O)c1cc(O)c(O)c(O)c21

Standard InChI:  InChI=1S/C13H8O8/c14-5-2-4-7(10(17)9(5)16)8-3(12(18)19)1-6(15)11(8)21-13(4)20/h2-3,14,16-17H,1H2,(H,18,19)

Standard InChI Key:  JFJWMFPFMLRLMI-UHFFFAOYSA-N

Associated Targets(Human)

Aryl hydrocarbon receptor 1071 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 292.20Molecular Weight (Monoisotopic): 292.0219AlogP: 0.66#Rotatable Bonds: 1
Polar Surface Area: 145.27Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.91CX Basic pKa: CX LogP: 0.41CX LogD: -3.92
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.56Np Likeness Score: 1.78

References

1. Lin L, Dai Y, Xia Y..  (2022)  An overview of aryl hydrocarbon receptor ligands in the Last two decades (2002-2022): A medicinal chemistry perspective.,  244  [PMID:36274276] [10.1016/j.ejmech.2022.114845]

Source